Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force

This publication has 151 references indexed in Scilit:

• When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
  PLOS ONE, 2013
• Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
  BMC Medicine, 2013
• An assessment of the construct validity of the ASCOT measure of social care-related quality of life with older people
  Health and Quality of Life Outcomes, 2012
• Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou test
  Canadian Medical Association Journal, 2011
• Guidance for Developers of Health Research Reporting Guidelines
  PLOS Medicine, 2010
• Dealing with heterogeneity of treatment effects: is the literature up to the challenge?
  Trials, 2009
• Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report
  Value in Health, 2009
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
  PLOS Medicine, 2007
• Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people
  BMJ, 2006
• A taxonomy of model structures for economic evaluation of health technologies
  Health Economics, 2006